# FDA Inspection 832423 - Biomat USA Inc - May 09, 2013

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/b96366dd-313a-4d43-a182-6f0236befa2f
Source feed: FDA_Inspections

> FDA Inspection 832423 for Biomat USA Inc on May 09, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 832423
- Company Name: Biomat USA Inc
- Inspection Date: 2013-05-09
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1174876 - 2022-06-29](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/a3884f75-b722-4a85-8f93-1c7f6531e91a)
- [FDA Inspection 1174876 - 2022-06-29](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/e045af29-b880-40b5-bfda-82add07144e2)
- [FDA Inspection 935614 - 2015-07-15](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/a64603e2-6226-404b-b407-90dbe5c5a232)
- [FDA Inspection 714404 - 2011-03-03](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/8c84b451-16ea-47bf-ab23-44a958d7927b)
- [FDA Inspection 565006 - 2009-02-12](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/4bb270f4-c381-4956-b564-c8a6553f6244)

Company: https://www.keypedia.com/companies/biomat-usa-inc/dec39741-a79f-4f3b-a172-d6a45ccb1260

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d